Skip to content

Improving Outcomes in Peritoneal Dialysis

Improving Outcomes in Peritoneal Dialysis: Identification and Characterization of Optimal Clinical Practice to Enhance Peritoneal Dialysis Catheter Functionality, Minimize Access-related Complications and Promote Peritoneal Dialysis as an Initiating Therapeutic Modality for Chronic Kidney Disease.

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02207751
Enrollment
0
Registered
2014-08-04
Start date
2014-09-30
Completion date
2017-08-31
Last updated
2016-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease, Peritoneal Dialysis Access

Keywords

Chronic Kidney Disease, Peritoneal Dialysis Access, Peritoneal Dialysis Catheter, Catheter Function

Brief summary

The objective is to understand the best way to place Peritoneal Dialysis (PD) catheters, and the best way to collect data regarding their function in England, Wales and Northern Ireland. Phase 1: We will carry out a detailed examination of existing returned pilot data with emphasis on data fields with poor data completeness and perform root cause analysis, and assess deficiencies in data field definition to identify improvements to be implemented. We will construct and disseminate electronic survey material to all study centres with targeted visits by the Principle Investigator undertaken. These visits will facilitate insight into local organization of data collection including interaction with designated individuals responsible for data returns. PD training days will be organized with emphasis on clinical practice feedback utilizing data acquired in the initial phases. Hospital Episode Statistics will be linked to existing acquired PD patient information to ensure the accuracy of collected data. An online data acquisition system will be developed to allow direct data entry from centres. Phase 2: On-going and sustained data acquisition performed on a prospective basis. Phase 3: Primary data analysis including clinical practice variation in England, Wales and Northern Ireland to identify site specific PD catheter functionality variation. Additionally, patient and site specific characteristics that predict clinical outcomes in PD will be identified and characterised. Phase 4: Clinical guidelines will be developed.

Interventions

None listed

Sponsors

Baxter Healthcare Corporation
CollaboratorINDUSTRY
Sheffield Teaching Hospitals NHS Foundation Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any adult (16 years or over) patient requiring first PD catheter placement

Exclusion criteria

* Patient less than 16 years

Design outcomes

Primary

MeasureTime frameDescription
Peritoneal dialysis catheter survival (sustained function) at 365 days post-insertion (insertion date)1 Year1. Functional (mechanical) catheter failure 2. Complication induced catheter failure - Infection, Hemorrhage, Dialysate Leakage & Bowel Perforation

Secondary

MeasureTime frameDescription
Missing DataBaseline & 1 YearMissing mandatory data fields
Mortality (all cause)Within 1 Year
Co-morbid Hospitalization EventsWithin 1 YearNon-fatal medical events requiring hospitalization, excluding PD related hospitalization
Time to catheter failureWithin 1 Year* Catheter failure time (days elapsed from insertion to failure \<365 days) * Catheter failure time (days elapsed from insertion to failure \>365 days)
Leak events not resulting in catheter failureWithin 1 Year* Catheter leak events (early): suspected or definite catheter site leak requiring intervention up to 2 weeks following catheter insertion * Catheter leak events (late): suspected or definite catheter site leak requiring intervention after 2 weeks following catheter insertion
Modality changeWithin 1 YearChange of modality from PD to any other form of renal replacement therapy
Catheter non-usageWithin 1 YearCatheters inserted but not used for reasons other than failed initial therapy (e.g. Moncrieff)
Infection events not resulting in catheter failureWithin 1 Year* Exit site / tunnel infection (early): suspected or definite infection around catheter exit site requiring intervention up to 2 weeks following catheter insertion * Exit site / tunnel infection (late): suspected or definite infection around catheter exit site requiring intervention after 2 weeks following catheter insertion * Peritonitis (early): peritonitis within 2 weeks of catheter insertion * Peritonitis (late): peritonitis after 2 weeks following catheter insertion

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026